In addition to his academic appointment, Dr. Wang is also the President and Chief Scientific Officer and co-founder of Auratus Bio, a biotech company specialized in animal genetic engineering. Dr. Wang’s research team employs modern genome engineering tools and assisted reproduction technologies (such as somatic cell nuclear transfer) to create genetically engineered animal models of human diseases. The Wang laboratory was the first succeeded in developing gene targeting tools in the golden Syrian hamster. Dr. Wang received his Ph.D. degree in molecular and cellular biology from University of Massachusetts at Amherst in 2000 and did his postdoctoral trainings at Massachusetts Institute of Technology.